Sunday, February 16, 2025

#Coronavirus Disease Research #References (by AMEDEO, Feb. 16 '25)

 


    Am J Obstet Gynecol

  1. DOMGUE JF, Chandra M, Yu R, Shete S, et al
    Adherence to cervical cancer screening among sexual and racial/ethnic minorities during the covid-19 pandemic in the United States.
    Am J Obstet Gynecol. 2025 Feb 7:S0002-9378(25)00088.
    PubMed        


    Antiviral Res

  2. SCHREIBER A, Ludwig S
    Host-targeted antivirals against SARS-CoV-2 in clinical development - Prospect or disappointment?
    Antiviral Res. 2025;235:106101.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  3. TORRES C, Lyden E, Gillett G, Rupp ME, et al
    Dropping the urine culture: sustained CAUTI reduction using a UTI order panel.
    Infect Control Hosp Epidemiol. 2025 Feb 13:1-7. doi: 10.1017/ice.2025.
    PubMed         Abstract available

  4. SAPIANO MRP, Dudeck MA, Patel PR, Binder AM, et al
    Patient safety as a measure of resilience in US hospitals: central line-associated bloodstream infections, July 2020 through June 2021.
    Infect Control Hosp Epidemiol. 2025 Feb 14:1-7. doi: 10.1017/ice.2024.
    PubMed         Abstract available


    Int J Infect Dis

  5. ZAMPIERI F, Michieletto F, Zanatta A
    Rise and fall of the Myth of the Good Pathogen in Evolutionary Biology and Medicine.
    Int J Infect Dis. 2025 Feb 5:107836. doi: 10.1016/j.ijid.2025.107836.
    PubMed         Abstract available

  6. LESLIE A, Chapman SA, Tessier KM, Tignanelli C, et al
    Beyond the Guidelines: Original Research on Real-World Outcomes of Anticoagulation and Corticosteroid in COVID-19.
    Int J Infect Dis. 2025 Feb 8:107834. doi: 10.1016/j.ijid.2025.107834.
    PubMed         Abstract available

  7. SHINZATO A, Hibiya K, Nishiyama N, Ikemiyagi N, et al
    Unseasonal respiratory syncytial virus epidemics during the COVID-19 pandemic: relationship between climatic factors and epidemic strain switching.
    Int J Infect Dis. 2025 Feb 8:107833. doi: 10.1016/j.ijid.2025.107833.
    PubMed         Abstract available


    Intensive Care Med

  8. ROWLAND A, Boulanger C, Dalton L
    Supporting the bereaved child in the adult ICU: a narrative review.
    Intensive Care Med. 2025 Feb 12. doi: 10.1007/s00134-025-07813.
    PubMed         Abstract available


    J Infect

  9. NOBLE C, McDonald E, Nicholson S, Biering-Sorensen S, et al
    Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response.
    J Infect. 2025 Feb 6:106436. doi: 10.1016/j.jinf.2025.106436.
    PubMed         Abstract available


    J Med Virol

  10. HIKMAT H, Le Targa L, Boschi C, Py J, et al
    Five-Year (2017-2022) Evolutionary Dynamics of Human Coronavirus HKU1 in Southern France With Emergence of Viruses Harboring Spike H512R Substitution.
    J Med Virol. 2025;97:e70217.
    PubMed         Abstract available

  11. MAO T, Zhang P, Jiang S, Li D, et al
    Oral Ad5 Vector-Based SARS-CoV-2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice.
    J Med Virol. 2025;97:e70236.
    PubMed         Abstract available

  12. KALO E, Basyouni Z, Katz GM, Karkvandi V, et al
    Real-World Effectiveness of Sotrovimab in Patients Infected With SARS-CoV-2 Omicron Subvariant BA.2 in Western Sydney, Australia.
    J Med Virol. 2025;97:e70235.
    PubMed         Abstract available

  13. BERGNA A, Lai A, Sagradi F, Menzo S, et al
    Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era.
    J Med Virol. 2025;97:e70215.
    PubMed         Abstract available

  14. ZHAO M, Lei L, Jiang Y, Tian Y, et al
    Unveiling the Threat of Disease X: Preparing for the Next Global Pandemic.
    J Med Virol. 2025;97:e70227.
    PubMed         Abstract available

  15. YE J, Zhang R, Zhou J, Xu T, et al
    Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS-CoV-2 via Combined Experiments.
    J Med Virol. 2025;97:e70229.
    PubMed         Abstract available

  16. MUKHOPADHYAY R, Lambisia AW, Hoang JP, Ravenhill BJ, et al
    Adenovirus-Specific T Cells in Adults Are Frequent, Cross-Reactive to Common Childhood Adenovirus Infections and Boosted by Adenovirus-Vectored Vaccines.
    J Med Virol. 2025;97:e70222.
    PubMed         Abstract available

  17. TORRES AR, Gaio V, Melo A, Lanca M, et al
    RSV-Bacterial Co-Infection Is Associated With Increased Illness Severity in Hospitalized Children - Results From a Prospective Sentinel Surveillance Study.
    J Med Virol. 2025;97:e70209.
    PubMed         Abstract available

  18. WANG S, Sun J, Hu Y, Zhang W, et al
    Clinical and Multiorgan Proteomics Characteristics of the Diverse Fatal Phase in Super Elderly Patients With SARS-CoV-2 Infection: A Descriptive Study.
    J Med Virol. 2025;97:e70207.
    PubMed         Abstract available


    J Virol

  19. CAO X, Liu Y, Tong W, Qin W, et al
    POLM inhibits porcine epidemic diarrhea virus replication by degrading multiple viral structural proteins.
    J Virol. 2025 Feb 10:e0227824. doi: 10.1128/jvi.02278.
    PubMed         Abstract available

  20. FURUSAWA Y, Kiso M, Uraki R, Sakai-Tagawa Y, et al
    Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures.
    J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217.
    PubMed         Abstract available

  21. ZHU H, Lou J, Yang Z, Bai J, et al
    STT3B promotes porcine epidemic diarrhea virus replication by regulating N-glycosylation of PEDV S protein.
    J Virol. 2025 Feb 13:e0001825. doi: 10.1128/jvi.00018.
    PubMed         Abstract available

  22. MA R, Zhang X, Li R, Dong X, et al
    PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
    J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085.
    PubMed         Abstract available


    Lancet

  23. WONG WC, Lin V, Fang X, Kidd M, et al
    The Lancet Commission on Transforming Primary Health Care in the Post-COVID-19 Era.
    Lancet. 2025 Feb 10:S0140-6736(25)00198-9. doi: 10.1016/S0140-6736(25)00198.
    PubMed        


    Lancet Infect Dis

  24. PROAL AD, Aleman S, Bomsel M, Brodin P, et al
    Targeting the SARS-CoV-2 reservoir in long COVID.
    Lancet Infect Dis. 2025 Feb 10:S1473-3099(24)00769.
    PubMed         Abstract available

  25. CHEN L, Kaku Y, Okumura K, Uriu K, et al
    Virological characteristics of the SARS-CoV-2 LP.8.1 variant.
    Lancet Infect Dis. 2025 Feb 10:S1473-3099(25)00079.
    PubMed        


    N Engl J Med

  26. FURIE RA, Rovin BH, Garg JP, Santiago MB, et al
    Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.
    N Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2410965.
    PubMed         Abstract available

  27. WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al
    VITT-like Monoclonal Gammopathy of Thrombotic Significance.
    N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930.
    PubMed         Abstract available

No comments:

Post a Comment

My New Space

Most Popular Posts